These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
716 related items for PubMed ID: 34291621
1. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment. Soliman A, Rogol AD, Elsiddig S, Khalil A, Alaaraj N, Alyafie F, Ahmed H, Elawwa A. J Pediatr Endocrinol Metab; 2021 Oct 26; 34(10):1263-1271. PubMed ID: 34291621 [Abstract] [Full Text] [Related]
2. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study. Soliman AT, Elawwa A, Itani M, Jour C, De Sanctis V. Acta Biomed; 2019 Sep 23; 90(8-S):43-51. PubMed ID: 31544806 [Abstract] [Full Text] [Related]
3. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center. Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, Soliman AT. Acta Biomed; 2020 Mar 19; 91(1):29-40. PubMed ID: 32191651 [Abstract] [Full Text] [Related]
4. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature. Liu HJ, Wang LH, Chen L. Adv Ther; 2019 Sep 19; 36(9):2374-2383. PubMed ID: 31301056 [Abstract] [Full Text] [Related]
5. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone? Colmenares A, González L, Gunczler P, Lanes R. J Pediatr Endocrinol Metab; 2012 Sep 19; 25(7-8):651-7. PubMed ID: 23155689 [Abstract] [Full Text] [Related]
6. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children. Hou L, Liang Y, Wu W, Lin HH, Luo XP, Ying YQ. Growth Horm IGF Res; 2020 Sep 19; 53-54():101331. PubMed ID: 32777706 [Abstract] [Full Text] [Related]
7. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group. Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B. Clin Endocrinol (Oxf); 1995 Apr 19; 42(4):365-72. PubMed ID: 7750190 [Abstract] [Full Text] [Related]
8. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone; 2005 Nov 19; 37(5):642-50. PubMed ID: 16139578 [Abstract] [Full Text] [Related]
12. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand. Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S. J Med Assoc Thai; 2007 Oct 19; 90(10):2047-52. PubMed ID: 18041422 [Abstract] [Full Text] [Related]
13. A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency. Gou P, Cheng X, Leng J, Su N. Ther Clin Risk Manag; 2022 Oct 19; 18():113-124. PubMed ID: 35342293 [Abstract] [Full Text] [Related]
14. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial]. Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW. Zhonghua Er Ke Za Zhi; 2009 Jan 19; 47(1):48-52. PubMed ID: 19573383 [Abstract] [Full Text] [Related]
16. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy. Ballerini MG, Braslavsky D, Scaglia PA, Keselman A, Rodríguez ME, Martínez A, Freire AV, Domené HM, Jasper HG, Bergadá I, Ropelato MG. Horm Res Paediatr; 2017 Jan 19; 88(5):354-363. PubMed ID: 28926833 [Abstract] [Full Text] [Related]